Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Feiner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Retina (Philadelphia, Pa.)|July 2, 2019
PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDYCalvin Mein, Pravin U Dugel, Leonard Feiner, et al.
Ophthalmology|April 20, 2010
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyPeter A Campochiaro, Jeffrey S Heier, Leonard Feiner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 16, 2006
Vitreous and aqueous penetration of orally administered moxifloxacin in humansSeenu M Hariprasad, Gaurav K Shah, William F Mieler, et al.
Ophthalmology|October 12, 2013
Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN studyPeter A Campochiaro, Raafay Sophie, Joel Pearlman, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
Investigative Ophthalmology & Visual Science|January 8, 2011
Generation of Cre transgenic mice with postnatal RPE-specific ocular expressionJared Iacovelli, Chen Zhao, Natalie Wolkow, et al.
Ophthalmology|February 15, 2012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEQuan Dong Nguyen, David M Brown, Dennis M Marcus, et al.
Ophthalmology|May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDEDavid M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Retina (Philadelphia, Pa.)|July 2, 2019
PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDYCalvin Mein, Pravin U Dugel, Leonard Feiner, et al.
Ophthalmology|April 20, 2010
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyPeter A Campochiaro, Jeffrey S Heier, Leonard Feiner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 16, 2006
Vitreous and aqueous penetration of orally administered moxifloxacin in humansSeenu M Hariprasad, Gaurav K Shah, William F Mieler, et al.
Ophthalmology|October 12, 2013
Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN studyPeter A Campochiaro, Raafay Sophie, Joel Pearlman, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
Investigative Ophthalmology & Visual Science|January 8, 2011
Generation of Cre transgenic mice with postnatal RPE-specific ocular expressionJared Iacovelli, Chen Zhao, Natalie Wolkow, et al.
Ophthalmology|February 15, 2012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEQuan Dong Nguyen, David M Brown, Dennis M Marcus, et al.
Ophthalmology|May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDEDavid M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Pageof 2